Science & Enterprise subscription

Follow us on Twitter

  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 hours ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 hours ago
  • While three medications for opioid abuse are approved by the Food and Drug Administration, the treatments are used… https://t.co/or9aOheyz2
    about 6 hours ago
  • New post on Science and Enterprise: Opioid Abuse Treatment Medications Underused https://t.co/MZu23y0YV4 #Science #Business
    about 6 hours ago
  • A clinical trial is getting underway to test five treatment candidates for amyotrophic lateral sclerosis, or ALS, b… https://t.co/7Pqc8mJyZ5
    about 1 day ago

Please share Science & Enterprise

Levitation Technique Devised to Create More Soluble Drugs

Levitating drug solution (Dan Harris, Argonne National Lab)

Levitating drug solution (Dan Harris, Argonne National Lab)

Researchers at Argonne National Laboratory, a division of the U.S. Department of Energy in Illinois, developed techniques making it more feasible to create drugs that are more soluble, and thus more effective in lower doses. X-ray physicist Chris Benmore led the study that uses levitation to suspend the solution in air while it evaporates, leaving a pristine sample of the compound.

Pharmaceuticals can be in either crystalline or amorphous form, with amorphous state being the more desirable because it yields drugs that are more efficiently processed by the body, a result of higher solubility and efficacy at lower doses. Most drugs, however, are in crystalline form.

The trick is to get compounds that start as solutions to transform into an amorphous state. Once in contact with a container, a solution takes the shape of its container and evaporation, when in contact with the container, is more likely to result in crystals.

Benmore then needed to find a way to capture finite amounts of a solution and allow them to evaporate with going into a container. To achieve this “containerless” capture, Benmore and colleagues turned to a technique developed at NASA to simulate microgravity conditions. The technique, called acoustic levitation, allows small, pristine samples of solutions to suspend in air while evaporation occurs.

Acoustic levitation uses two small speakers, vertically and precisely aligned, to generate sound waves at a frequency slightly above the audible range at 22 kilohertz. The speakers each then produce a set of sound waves that interfere with each other, creating what is called a standing wave.

The standing wave has points, called nodes, where no net transfer of energy occurs. The acoustic pressure from the sound waves at the nodes is sufficient to cancel the effect of gravity, allowing light objects to suspend in air when placed at the nodes.

Argonne researchers so far have tried levitation on some 12 current drug compounds. At this time, however, only small quantities of of a drug can be made amorphous using this technique.

The lab’s technology transfer office filed a patent for this process, and is seeking a licensing partner in the pharmaceutical industry to develop the technology further. Argonne is also partnering with pharmacy and chemistry researchers at Purdue University and Arizona State to identify the drugs on which levitation can have the most impact.

In the following video. Chris Benmore demonstrates the levitation technique.

Read more:

*     *     *

Please share Science & Enterprise ...
error

1 comment to Levitation Technique Devised to Create More Soluble Drugs